Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast…
Atezolizumbab is the first immunotherapy drug to be approved globally for treatment of unresectable locally advanced and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
TNBC
Invictus Oncology to present data on IO-125 at Breast Cancer Symposium
IO-125, a novel supramolecular platinum chemotherapy, is being developed in Triple-Negative Breast Cancer (TNBC) Invictus…